Paris-based En Carta secures €1.5 million pre-seed to advance platform for early Lyme disease detection
En Carta Diagnostics, a deeptech startup developing rapid Point-of-Care (POC) molecular diagnostics kits, announced €1.5 million in pre-seed funding. This investment will enable En Carta to make a substantial leap forward in achieving preclinical data on a …